Suraj Samtani, Medical Oncologist at Harvard Medical School, shared on X:
“Honoured to share data and our experience on the management of Lung Cancer with ALK mutation at ALKLINIC in Sao Paulo with great colleagues around the world.”
Source: Suraj Samtani/X